GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » 111 Inc (NAS:YI) » Definitions » EV-to-EBITDA

111 (YI) EV-to-EBITDA : -3.80 (As of May. 10, 2024)


View and export this data going back to 2018. Start your Free Trial

What is 111 EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, 111's enterprise value is $177 Mil. 111's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $-46 Mil. Therefore, 111's EV-to-EBITDA for today is -3.80.

The historical rank and industry rank for 111's EV-to-EBITDA or its related term are showing as below:

YI' s EV-to-EBITDA Range Over the Past 10 Years
Min: -29.73   Med: -6.03   Max: -0.93
Current: -3.8

During the past 8 years, the highest EV-to-EBITDA of 111 was -0.93. The lowest was -29.73. And the median was -6.03.

YI's EV-to-EBITDA is ranked worse than
100% of 80 companies
in the Medical Distribution industry
Industry Median: 10.415 vs YI: -3.80

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-10), 111's stock price is $1.14. 111's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.648. Therefore, 111's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


111 EV-to-EBITDA Historical Data

The historical data trend for 111's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

111 EV-to-EBITDA Chart

111 Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial -7.14 -8.04 -4.29 -7.10 -4.56

111 Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.10 -7.58 -9.29 -8.31 -4.56

Competitive Comparison of 111's EV-to-EBITDA

For the Medical Distribution subindustry, 111's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


111's EV-to-EBITDA Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, 111's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where 111's EV-to-EBITDA falls into.



111 EV-to-EBITDA Calculation

111's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=176.590/-46.466
=-3.80

111's current Enterprise Value is $177 Mil.
111's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-46 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


111  (NAS:YI) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

111's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=1.14/-0.648
=At Loss

111's share price for today is $1.14.
111's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.648.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


111 EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of 111's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


111 (YI) Business Description

Traded in Other Exchanges
Address
No.295 ZuChongZhi Road, 3rd-5th Floors, Pudong New Area, Shanghai, CHN, 201203
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.

111 (YI) Headlines